查看購物車
  • Simplified Chinese
  • English
歐洲醫療外骨骼市場預測（至2031年）-區域分析-按組件、類型、肢體、應用、移動性和最終用戶
市場調查報告書
商品編碼
1715173

歐洲醫療外骨骼市場預測（至2031年）-區域分析-按組件、類型、肢體、應用、移動性和最終用戶

Europe Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users
出版日期: | 出版商: The Insight Partners | 英文 117 Pages | 訂單完成後即時交付

價格

2023年歐洲醫療外骨骼市場價值為1.0748億美元，預計到2031年將達到8.5396億美元；預計2023年至2031年的複合年成長率為29.6%。

中風和肌肉骨骼發生率不斷上升推動歐洲醫療外骨骼市場

儘管醫療產業取得了進步，但中風仍然是一個主要的公共衛生問題。中風是全球第二大死因，也是導致殘疾的主要原因。根據《2022 年全球中風說明書》，過去 17 年間，一生中中風的風險上升了 50%，預計每 4 人中就有 1 人會在一生中的某個時刻患上中風。 1990年至2019年間，中風發生率上升了70%，中風相關死亡人數上升了43%，中風頻率上升了102%，傷殘調整生命年（DALY）上升了143%。最值得注意的是，中低收入國家佔世界中風負擔的絕大部分（佔中風相關死亡人數的 86% 和 DALY 的 89%）。 2017年，歐盟共發生112萬起中風事件，953萬名中風倖存者，46萬例中風相關死亡，以及706萬年因中風致殘而損失的壽命。此外，預計2017年至2047年間，中風患者數量將增加27%，主要是由於人口老化和存活率提高。預計各國之間仍將存在差異，這表明病例管理和預防方面有進步的潛力，尤其是在東歐。因此，中風發病率的不斷上升增加了對中風患者復健的外骨骼系統的需求，以幫助改善生活品質。

此外，肌肉骨骼疾病會影響個人的活動能力。肌腱炎、骨質減少、肌少症和腰背部損傷等肌肉骨骼疾病的盛行率不斷上升，導致對外骨骼機器人系統的需求日益成長。根據世界衛生組織 (WHO) 的數據，全球約有 17.1 億人患有肌肉骨骼疾病，下背部疼痛是 160 個國家的主要殘疾原因。這些外骨骼可以幫助患者控制疼痛，恢復活動能力，從而提高他們的整體生活品質。因此，中風和肌肉骨骼疾病的盛行率不斷上升，導致人們使用外骨骼機器人系統進行復健治療。

歐洲醫療外骨骼市場概況

歐洲醫療外骨骼市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。該地區在全球醫療外骨骼市場佔有相當大的佔有率，預計將實現顯著的複合年成長率。該國的市場參與者正在採用合作夥伴關係和協作等無機成長策略來擴大和成長市場。 2022年8月，德國Bionic公司（智慧動力服飾開發領域的全球技術領導者）與Mubea公司（德國頂級汽車供應商）達成合作協議。透過協助世界頂級機器人外骨骼開發商進行生產，Mubea 進入了一個全新且前景廣闊的未來領域。同樣，2020 年 4 月，ReWalk Robotics Ltd. 宣布與德國頂級法定健康保險公司 (“SHI”)、Deutsche Angestellten-Krankenkasse - Gesundheit (“DAK-Gesundheit”) 和 Techniker Krankenkasse (“TK”) 達成協議。本協議允許任何符合資格的脊髓損傷受益人獲得 ReWalk 6.0 外骨骼系統。 TK 和 DAK 分別代表德國 1,060 萬和 560 萬名受益人，是德國最大的兩家 SHI；這些協議有望幫助德國制定外骨骼採購標準。

歐洲醫療外骨骼市場收入及預測（2031年）（百萬美元）

歐洲醫療外骨骼市場細分

歐洲醫療外骨骼市場分為組件、類型、肢體、應用、移動、最終用戶和國家。

根據組成部分，歐洲醫療外骨骼市場分為硬體和軟體。 2023 年，硬體部分佔據了歐洲醫療外骨骼市場的較大佔有率。

從類型來看，歐洲醫療外骨骼市場分為動力外骨骼和被動外骨骼。 2023 年，動力外骨骼領域佔據了歐洲醫療外骨骼市場的較大佔有率。

根據肢體，歐洲醫療外骨骼市場分為下半身外骨骼、上半身外骨骼和全身外骨骼。 2023 年，下肢外骨骼領域佔據歐洲醫療外骨骼市場的最大佔有率。

根據應用，歐洲醫療外骨骼市場分為脊髓損傷、多發性硬化症、中風、腦性麻痺、巴金森氏症等。 2023 年，脊髓損傷領域佔據歐洲醫療外骨骼市場的最大佔有率。

就移動性而言，歐洲醫療外骨骼市場分為移動外骨骼和固定外骨骼。 2023 年，動力外骨骼領域佔據了歐洲醫療外骨骼市場的較大佔有率。

根據最終用戶，歐洲醫療外骨骼市場分為復健中心、物理治療中心、長期照護中心、家庭護理機構等。 2023 年，復健中心部門佔據歐洲醫療外骨骼市場的最大佔有率。

根據國家/地區，歐洲醫療外骨骼市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2023 年，德國佔據歐洲醫療外骨骼市場的最大佔有率。

比奧尼克； B-Temia 公司； Cyber​​dyne公司； Ekso Bionics Holdings Inc； ExoAtlet；霍科馬股份公司； Lifeward 公司； Myomo 公司； Rex Bionics 有限公司；和 Wearable Robotics SR 是歐洲醫療外骨骼市場的一些領先公司。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：歐洲醫療外骨骼市場-關鍵市場動態

  • 歐洲醫療外骨骼市場-關鍵市場動態
  • 市場促進因素：
    • 策略舉措不斷增加
    • 中風和肌肉骨骼疾病發生率不斷上升
    • 老年人口壽命延長
  • 市場限制
    • 產品成本高且監管問題
  • 市場機會
    • 脊髓損傷盛行率不斷上升
  • 未來趨勢
    • 科技進步不斷加快，投資不斷增加
  • 促進因素和限制因素的影響：

第5章：歐洲醫療外骨骼市場分析

  • 2021-2031年歐洲醫療外骨骼市場收入
  • 歐洲醫療外骨骼市場預測分析

第6章：歐洲醫療外骨骼市場分析-按組件

  • 硬體
  • 軟體

第7章：歐洲醫療外骨骼市場分析-依類型

  • 動力外骨骼
  • 被動外骨骼

第 8 章：歐洲醫療外骨骼市場分析 - 按 Extremity

  • 下肢外骨骼
  • 上身外骨骼
  • 全身外骨骼

第9章：歐洲醫療外骨骼市場分析-按應用

  • 脊髓損傷
  • 多發性硬化症
  • 中風
  • 腦性麻痺
  • 帕金森氏症
  • 其他

第 10 章：歐洲醫療外骨骼市場分析 - 依移動性

  • 移動外骨骼
  • 固定式外骨骼

第 11 章：歐洲醫療外骨骼市場分析 - 按最終用戶

  • 復健中心
  • 物理治療中心
  • 長期照護中心
  • 家庭護理設置
  • 其他

第 12 章：歐洲醫療外骨骼市場-國家分析

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 13 章：醫療外骨骼市場-產業格局

  • 概述
  • 醫療外骨骼市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 14 章：公司簡介

  • Ekso Bionics Holdings Inc
  • Lifeward, Inc
  • ExoAtlet
  • Cyberdyne Inc
  • BIONIK
  • B-Temia Inc
  • Hocoma AG
  • Wearable Robotics SRL
  • Myomo Inc
  • Rex Bionics Ltd.

第 15 章：附錄

Product Code: BMIRE00031138

The Europe medical exoskeleton market was valued at US$ 107.48 million in 2023 and is expected to reach US$ 853.96 million by 2031; it is estimated to register a CAGR of 29.6% from 2023 to 2031.

Growing Incidence of Stroke and Musculoskeletal Drives Europe Medical Exoskeleton Market

Despite the advancements in the medical industry, stroke continues to be a major public health issue. Stroke ranks second in the world in terms of causes of mortality and is the main cause of disability. According to the Global Stroke Factsheet 2022, the lifetime risk of having a stroke has risen by 50% in the past 17 years, with an estimated 1 in 4 people expected to experience one at some point in their lives. Between 1990 and 2019, there was a rise of 70% in the incidence of stroke, 43% in the number of stroke-related deaths, 102% in the frequency of stroke, and 143% in Disability Adjusted Life Years (DALY). The most notable aspect is that lower- and lower-middle-income countries account for the majority of the world's stroke burden (86% of stroke-related fatalities and 89% of DALYs). In the European Union, there were 1.12 million stroke incidents, 9.53 million stroke survivors, 0.46 million stroke-related deaths, and 7.06 million years of life lost due to disability from stroke in 2017. Further, the number of people living with stroke is predicted to rise by 27% between 2017 and 2047, primarily as a result of aging populations and higher survival rates. It is anticipated that differences will continue to exist between nations, indicating potential for advancements in case management and prevention, especially in Eastern Europe. Therefore, the increasing incidences of stroke have boosted the demand for exoskeleton systems for rehabilitation of stroke patients to help improve the quality of life.

In addition, musculoskeletal disorders impact the mobility of an individual. The increasing prevalence of musculoskeletal disorders, such as tendinitis, osteopenia, sarcopenia, and low back injuries, result in a growing need for exoskeletan robotic systems. According to the World Health Organization (WHO), ~1.71 billion people globally are affected by musculoskeletal diseases, and lower back pain is a leading cause of disability in 160 countries. These exoskeletons assist patients in managing their pain, as well as help regain their mobility, thereby improving their overall quality of life. Thus, the increasing prevalence of stroke and musculoskeletal disorders has led to the use of exoskeletan robotic systems for rehabilitation.

Europe Medical Exoskeleton Market Overview

The European medical exoskeleton market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global medical exoskeleton market and is expected to register a notable CAGR. Market players in the country are adopting inorganic growth strategies such as partnerships and collaborations for market expansion and growth. In August 2022, German Bionic (a global technology leader in the development of smart power suits) and Mubea (the top German automotive supplier) entered a cooperation agreement. By assisting the world's top developer of robotic exoskeletons in production, Mubea tapped into a new and quite promising future sector. Similarly, in April 2020, ReWalk Robotics Ltd. announced the national agreement with top German Statutory Health Insurers ("SHI"), Deutsche Angestellten-Krankenkasse - Gesundheit ("DAK-Gesundheit"), and Techniker Krankenkasse ("TK"). This agreement can permit any eligible beneficiary with a spinal cord injury to get a ReWalk 6.0 exoskeleton system. TK and DAK, representing 10.6 million and 5.6 million beneficiaries in Germany, respectively, are two of the largest SHIs in the country; these agreements are expected to help set the standard for exoskeleton procurement in Germany.

Europe Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

Europe Medical Exoskeleton Market Segmentation

The Europe medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the Europe medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Europe medical exoskeleton market share in 2023.

In terms of type, the Europe medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Europe medical exoskeleton market share in 2023.

Based on extremity, the Europe medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Europe medical exoskeleton market share in 2023.

By application, the Europe medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the Europe medical exoskeleton market share in 2023.

In terms of mobility, the Europe medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Europe medical exoskeleton market share in 2023.

By end users, the Europe medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Europe medical exoskeleton market share in 2023.

Based on country, the Europe medical exoskeleton market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe medical exoskeleton market in 2023.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; Rex Bionics Ltd.; and Wearable Robotics SR are some of the leading companies operating in the Europe medical exoskeleton market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Medical Exoskeleton Market - Key Market Dynamics

  • 4.1 Europe Medical Exoskeleton Market - Key Market Dynamics
  • 4.2 Market Drivers:
    • 4.2.1 Rising Number of Strategic Initiatives
    • 4.2.2 Growing Incidence of Stroke and Musculoskeletal
    • 4.2.3 Increasing Longevity of Aging Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Product and Regulatory Concerns
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Prevalence of SCI
  • 4.5 Future Trends
    • 4.5.1 Increasing Technological Advancements and Rising Investments
  • 4.6 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - Europe Analysis

  • 5.1 Europe Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Medical Exoskeleton Market Forecast Analysis

6. Europe Medical Exoskeleton Market Analysis - by Component

  • 6.1 Hardware
    • 6.1.1 Overview
    • 6.1.2 Hardware: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Software
    • 6.2.1 Overview
    • 6.2.2 Software: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Medical Exoskeleton Market Analysis - by Type

  • 7.1 Powered Exoskeleton
    • 7.1.1 Overview
    • 7.1.2 Powered Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Passive Exoskeleton
    • 7.2.1 Overview
    • 7.2.2 Passive Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Medical Exoskeleton Market Analysis - by Extremity

  • 8.1 Lower Body Exoskeleton
    • 8.1.1 Overview
    • 8.1.2 Lower Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Upper Body Exoskeleton
    • 8.2.1 Overview
    • 8.2.2 Upper Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Full Body Exoskeleton
    • 8.3.1 Overview
    • 8.3.2 Full Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Medical Exoskeleton Market Analysis - by Application

  • 9.1 Spinal Cord Injury
    • 9.1.1 Overview
    • 9.1.2 Spinal Cord Injury: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Multiple Sclerosis
    • 9.2.1 Overview
    • 9.2.2 Multiple Sclerosis: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Stroke
    • 9.3.1 Overview
    • 9.3.2 Stroke: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Cerebral Palsy
    • 9.4.1 Overview
    • 9.4.2 Cerebral Palsy: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Parkinson's Diseases
    • 9.5.1 Overview
    • 9.5.2 Parkinson's Diseases: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Medical Exoskeleton Market Analysis - by Mobility

  • 10.1 Mobile Exoskeleton
    • 10.1.1 Overview
    • 10.1.2 Mobile Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Stationary Exoskeleton
    • 10.2.1 Overview
    • 10.2.2 Stationary Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Medical Exoskeleton Market Analysis - by End Users

  • 11.1 Rehabilitation Centers
    • 11.1.1 Overview
    • 11.1.2 Rehabilitation Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Physiotherapy Centers
    • 11.2.1 Overview
    • 11.2.2 Physiotherapy Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Long Term Care Centers
    • 11.3.1 Overview
    • 11.3.2 Long Term Care Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Homecare Settings
    • 11.4.1 Overview
    • 11.4.2 Homecare Settings: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Medical Exoskeleton Market - Country Analysis

  • 12.1 Europe Medical Exoskeleton Market
    • 12.1.1 Europe Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.1.2 Germany: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.1.3 Germany: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.1.4 Germany: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.1.5 Germany: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.1.6 Germany: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.2 United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.2.1.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.2.1.1.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.2.2 United Kingdom: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.2.3 United Kingdom: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.2.4 United Kingdom: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.2.5 United Kingdom: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.2.6 United Kingdom: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.3 France: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 France: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.3.1.1 France: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.3.1.1.1 France: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.3.2 France: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.3.3 France: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.3.4 France: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.3.5 France: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.3.6 France: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.4 Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Italy: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.4.1.1 Italy: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.4.1.1.1 Italy: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.4.2 Italy: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.4.3 Italy: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.4.4 Italy: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.4.5 Italy: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.4.6 Italy: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.5 Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Spain: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.5.1.1 Spain: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.5.1.1.1 Spain: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.5.2 Spain: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.5.3 Spain: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.5.4 Spain: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.5.5 Spain: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.5.6 Spain: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.6 Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.6.1.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.6.1.1.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.6.2 Rest of Europe: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.6.3 Rest of Europe: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.6.4 Rest of Europe: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.6.5 Rest of Europe: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.6.6 Rest of Europe: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Medical Exoskeleton Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Ekso Bionics Holdings Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Lifeward, Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 ExoAtlet
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Cyberdyne Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 BIONIK
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 B-Temia Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Hocoma AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Wearable Robotics SRL
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Myomo Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Rex Bionics Ltd.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Medical Exoskeleton Market Segmentation
  • Table 2. Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Medical Exoskeleton Market, by Hardware - Revenue and Forecast to 2031 (USD Million)
  • Table 4. Europe Medical Exoskeleton Market, by Actuators - Revenue and Forecast to 2031 (USD Million)
  • Table 5. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 6. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 7. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 8. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 9. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 10. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 11. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 12. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 13. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 14. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 15. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 16. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 17. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 18. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 19. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 20. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 21. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 22. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 23. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 24. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 25. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 26. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 27. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 28. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 29. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 30. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 31. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 32. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 34. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 35. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 36. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 37. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 38. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 39. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 40. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 41. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 42. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 43. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 44. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 45. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 46. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 47. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 48. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 49. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 50. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 51. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 52. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 53. Recent Organic Growth Strategies in Medical Exoskeleton Market
  • Table 54. Recent Inorganic Growth Strategies in the Medical Exoskeleton Market
  • Table 55. Glossary of Terms, Medical Exoskeleton Market

List Of Figures

  • Figure 1. Europe Medical Exoskeleton Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • Figure 4. Europe Medical Exoskeleton Market Share (%) - by Component (2023 and 2031)
  • Figure 5. Hardware: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 6. Software: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Europe Medical Exoskeleton Market Share (%) - by Type (2023 and 2031)
  • Figure 8. Powered Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Passive Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Europe Medical Exoskeleton Market Share (%) - by Extremity (2023 and 2031)
  • Figure 11. Lower Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Upper Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Full Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Europe Medical Exoskeleton Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Spinal Cord Injury: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Multiple Sclerosis: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Stroke: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Cerebral Palsy: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Parkinson's Diseases: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Europe Medical Exoskeleton Market Share (%) - by Mobility (2023 and 2031)
  • Figure 22. Mobile Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Stationary Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Europe Medical Exoskeleton Market Share (%) - by End Users (2023 and 2031)
  • Figure 25. Rehabilitation Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Physiotherapy Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Long Term Care Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Homecare Settings: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Europe Medical Exoskeleton Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 31. Europe Medical Exoskeleton Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 32. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Growth Strategies in Medical Exoskeleton Market